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Considerable indirect evidence suggests that T lym.-
phocytes have a role in the pathogenesis of psoriasis. 
The goal of this study was to directly test the ability 
ofT cells to maintain psoriasis pathology. Psoriatic 
skin was transplanted onto SCID mice, which were 
then injected with autologous T cells. T cells were 
cultured from either psoriatic skin lesions or periph-
eral blood and injected intradermally or intrave-
nously. Control SCID mice transplanted with psoria-
sis grafts were not injected with T cells. After 10 wk, 
control psoriatic skin grafts not injected with T cells 
lost many of the features of psoriasis. Injection of 
peripheral blood T cells was not able to maintain 
these psoriatic features. In contrast, the injection of 
P soriasis is a disease of e pider.mal k eratinocy.te h. yper-prolife ration , whic h is believed to be driven by cyto-kines and growth factors produced by cells of the itnmune system . fmmunohistoch e mi ca l studies of pso-riati c plagues show evidence ofT -cell activa tion and 
cytokine pmduction (Valdimarsson et nl, 1986; Gottlieb, 1988; 
Nicoloff, 1991; Bata-Csorgo et nl, 1 995). T h e importance ofT cells 
to the pathogenesis of tlus disease is further supported b y the 
efficacy of immunosuppressive the rapy such as anti- CD4 monoclo-
nal antibodies, inte rl e ukin-2 (lL- 2)/ diphthe ria toxin fusion protein 
(DAB389 IL-2) , and cyclospori.n A (Prinz et nl, 1991; J egasothy et 
nl, 1992; Gottlieb et nl, 1995). 
The aim of the current study was to achi eve a mode l of psoriasis 
by the transfer of human psoriati c lesioual skin and autologou · 
lymphocytes to severe combined immunode fi c ie n cy (SClD) mice. 
Lymphocytes isolated from psoriatic skin were c ulture d i11 11itro and 
inj ected intradermally (ID) or intravenously (TV) into human skin 
explants e n g rafted to SCID mice. Grafts were removed from the 
SCID mice at 10 wk for ana lysis. It was found that transfer ofT cell s 
fiom les ional skin was able to maintain the phe notype of a psoriasis 
lesion . 
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T cells derived from psoriatic skin was able to main-
tain the psoriatic phenotype. Psoriatic features that 
were maintained included epidern'lal thickness and 
labeling index and expression of HLA-DR, involu-
crin, and ICAM-1, as well as loss of expression of 
filaggrin. Injection of skin infiltrating T cells into 
skin of normal donors on SCID mice did not induce 
changes of psoriasis. The ability of T cells from 
lesional skin, but not peripheral blood, to maintain 
psoriasis suggests that psoriasis is mediated by an 
autoantigen reactive T cell, which is present at a 
higher frequency in the psoriatic lesion. Key wovds: 
epidem1a I pvolifera.tioul epiduma I dij'el'ell tia tionlpsoJtiasisl 
ICAM-1.] I1west Dennatol 109:283-288, 1997 
MATERJALS AND METHODS 
Animals Outbrcd SC ID mice (Charles l~vcr, U .K.) 2-3 mo of age, were 
used in thi s stud y. The mice were raised in the pathogcn-fi·ce animal f.1c ility 
of the B. R appaport Faculty of Medicine, Technion-lst·acl Institute of 
Technology. 
Patients After rcceivi.ng approva l of the loca l ethics committee, 20 
psoriatic patients were included in this stud y. Skin from six patie nts was 
used for the initial cxpct;tncnts vlith peripheral blood n1ononuclcar ccUs 
(PBMC). Skin fi·01n the remaining 14 patients was used in experiments w ith 
sk in- in fi ltrating lymphocytes. Lesiona l psoriatic skin was obtained fi·om the 
thighs of each patient by electrical dermatome (Brown 666, Z immer, 
Warsaw. IN) . Normal skin obta ined fi·01n nine no npsoriatic subjects who 
underwent surgica l p rocedures at the Plastic Department of the Ram bam 
Medica l Cente r, 1-laif:t , se rved as a contro l gmup. Because of the lower 
density of lymphocytes. the arc<~ of the normal skin used for l)~nphocy te 
isolation \-Va !'i la rge r than for psorintic skin (nonnal 24 c n1 :.'! llf.!.rsus 6 ctn 2 for 
psoriatic skin) . Biopsies were sectioned; half was grafted onto SCID mice, 
and the other half was divided into four p ieces for th e fo llowing studies: (i) 
Histologic analysis of paraffin-embedded specim ens; (ii) Determination of 
labeling index by autoradiography; (iii) Immunohistochemi ca l anal ysis; (iv) 
lsoh1tion and culture ofT lymphocytes for transfer to the grafted mice. 
Isolation and Culture of T Cells from Skin Lymphocytes were 
isolated from skin biopsies as described previously (Ka lish and J o hnson, 
1990; Ka lish er nl, 1992). Briefly, the skin biopsy was minced into 1-mm' 
pieces and inc uba ted on a rotating pla tfo rm with 2 m l medium RPM I I 640 
conta injng 2 m g collagen;tSe per ml (Sigma , StLouis, MO) for 1 h at 37.°C. 
T cells were separated by centrifugatio n o n Histopaque 1077 (Sigma). 
Retrieval ofT cell s averaged 500,000 per biopsy. T-cell s were seeded at 
5000 ce lls/well in 0.2 ml complete medium (KPMI 1640) containing H)'Y,, 
human AI3 serum (Sigma), 2 mM glutamine . I 00 U penicillin per mi. and 5 
m g streptomycin per mi. in 96 flat-bottom wells (Corning). All wells 
contained irradiated (30001"t) autologous PBMC (2 X 1 o·'hve ll) as antigen 
presenting cell s, as we ll as auto logous epidermal and dcnnal ce ll s (ke ra ti-
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nocytcs, fibroblasts) (2 X t O' ) derived fi·om the skin biopsy as a source of 
antigen. After 3 d of cul ture, hum a11 recombinant IL-2 (Genzyme, Cam-
bridge, MA) , 10 U per m l, was added, and the medium was thereafte r 
changed every 3- 4 d. C ultures were examined dail y for growth and wells 
containing T cells were passaged to 24-well plates (Corning, Corning, NY). 
Cell s we re maintained in the same complete medium in the presence of 1 0 
U I L-2 per ml and aurin tricarboxylic acid (Sigma), 0.2 mg per mi. 
Aurintricarbox-ylic acid is an endonuclease inhibito r, which prevents ape-
ptosis of human T-cell s, promoting prolonged in 11 itro culture .' On day 
25-35 ofT-cell culture, ce lls were collected (average 7.2 X 106 for each 
group). An aliquot of each culture was phenotyped by immunohistochem-
istry, and the remaining ce ll s were injected in to m.ice. 
Immunohistochemistry An aliquot of the cell suspension was centri-
fuged by using a cytocentrifuge (Cytospin, Shandon Southern Instruments, 
Sewickley, PA), spinning approximately 50,000 cells at 500 rpm for 5 min 
onto a glass slide. Cell s were air-dried and stained immunohistochemically 
using anti-CD3 (Dako, Cm-pinte ria , C A) , anti-CD4, anti-COB (Caltag 
Laborat01ies, San Francisco, CA), fo llowed by a biotin-avidin detection 
system (Vectostain, Vector Laboratories, Burlingame, CA). T he phenotype 
of each cell cu lture was determined by counting at least 300 cells/slide. The 
T -cell lines iso lated from cultures of psoriati c and normal skin were CD3 + 
(9B%), CD4+ (52% and 72%, respectively), and COB + (47% and 26%, 
respective ly). 
Identification of Human T Cells in Mouse Spleens Mouse spleens 
were grated aga inst a 0.3 X 0.3-mm metallic mesh immersed in RPMJ 1640 
supplemented with 10% feta l bovine serum, 1% penicillin, 1% streptom ycin , 
and 1% glutamine . Spleen cell snspensions were stained with anti-human 
CD3 antibody directly conjugated to flu o resce in isothiocyanatc (Becton 
Dickinson , San J ose, C A) , and analyzed by cytofluorograph (FACScan, 
Becton Dickinson). Mouse lgG conjugated to fluoresce in isothiocya natc 
was used as a negative con trol antibody. 
Skin Transplantation and Injection of Autologous Lymphocytes 
Skin transplantation was performed as described previously (Gilhar e/ a/, 
1993 , 1995) . Skin from each patient was transplanted onto six mice, whkh 
were divided into three groups (two mice each) and injected with T cell s 4 
wk following skin engraftment. T he first group rece ived intraveno us (IV) 
injections of cultured T lymphocytes. The second group received intrader-
mal (ID) injections, directly in to the human grafts, of the same cultured T 
lym phocytes. The number ofT ce lls transferred was l.B X 106 ce lls/mouse 
in 0.5 ml of medium tU>MI 1640 . T he third gro up served as control and was 
not injected. 
A similar procedure was performed for SClD mice bearing normal skin 
fi·om normal donors . T he normal g rafts received the same number o f 
autologous T ce ll s (1.8 X ·1 0(' cells/mo use in 0.5 ml R..PM! medium) . 
Six weeks after lymphocyte injection (1 0 wk after engraftment) the grafts 
we re harvested . T he first gra ft from each group was used for lymphocyte 
iso la tion, and the second graft was divided into four pieces for tl1e following 
procedures: (i) Fixation in form alin and paraffin embedding; (ii) Embedding 
in OCT compound; (iii) Isolation of inflammatory ce lls followed by 
cytospin preparation fo r phenotype studies; (iv) Determination of labeling 
index. Terminal differentiation of graft epidermis was assessed by immune-
peroxidase loca lization of keratin, fi laggrin, and in volucrin . 
Determination of Epidermal Thickness Histologic assessment of the 
grafts was performed by light microscopy bodt before and after transplan-
tation. Epidermal thickness was determined with an ocular micrometer, at a 
min.imum of 20 points along the epidermis selected to represent points of 
tnax.i1nal and rninin1al thickness. 
Labeling Index Determined by Autoradiography Bo th prio r to and 
after grafting, pieces of tissue (1- 2 mm) were incubated for 4 h in a shaking 
incubator at 37°C in 1 ml RPMI containing 4 fLI (3 H] thymidine {specific 
ac tivity 20 C i/ mmol) at a concentration of 2.5 mCi per ml (New England 
Nuclear, Boston, MA). Autorad.iographs were prepared using the dipping 
technique, and epiderm al labeling indices indicated the percen tage of 
labeled cell s counted in 1000 basal cells. 
Immunohistochemical Staining Monoclonal antibodies to human an-
tigens used were as follows: 'mti-HLA-DR (Dako), anti-CD3 {Dako), 
anti-CD4, anti-COS (Cal tag Laboratories), anti-COlla, anti-CDl8 {Dako), 
anti-CD54 intercellular adhesion molecule-1 (ICAM- 1.) (Biodesign, Car-
mel, NY) , anti-involucrin , anti-filaggrin (Biomedica l Technologies Inc., 
Sto ughton , MA) , and anti-cytokeratin 16 (Sigma). The following antibodies 
1 Ka lish RS, Wood JA: Apoptosis iJ1hibitor aurintricarboxylic acid pro-
motes in. vitro surviva l of antigen specific hum an T -lymphocytes. J hwesl 
Der111atol 1 04:6BO, 1995 (abstr). 
T HE J OURNAL OF INVESTIGATIV E DERMATOLOGY 
Table I. Peripheral Blood Lymphocytes Are Unable to 
Maintain the Psoriatic Phenotype" 
Treatment 
lnitial va lue 
Not injected 
IV injection 
m injection 
Epidermal Thickness 
84.2 :':: 8.01' 
61.6 :':: 6.3 
63.9 :':: 6.B 
69.6 :':: B.3 
Labeling Index (U) 
17.0 :':: 14 .7' 
9.0 :':: 0 .9 
6.7 :':: 10.2 
8.2 :':: 0.6 
" C ul tured autologous PBM C from six patients were inj ected either intrave no usly 
(IV) or intradcrm ally (10) in to psoriasis grafts on SC ID mice . Grafts were harvested at 
6 wk. Differences i11 labcl.ing index between initial values and nonjnjcctcd grafts are 
significan t (p < 0.05 by t tes t). 
11 T hickn ess in nticrons :':: SEM . 
' Ll ± SEM . 
to murine antigens were used , anti-mouse C D 3 (Caltag) , and polyclonal 
rabbit anti-mouse asialo GM-1 (Wako Chemicals, Dallas, TX) . Immuno-
histochemistry was perfo rmed on OCT embedded specimens with a 
biotin-avidin system (Vectostain, Vec tor Laboratori es, Burlingame, CA). 
Enumeration of CD3, CD4, and COB-positive T cells throughout the 
epidem1is and dermis of coded specimens was assessed by two independent 
observers , who were blind to the coding , using a standard square at a 400 X 
magnifi cation . The results for epidermis and dermis were expressed as ce ll s 
per 1.5 mm2 
Statistical Analysis All stati sti cal comparisons were performed using 
analysis of variance {AN OVA), Student's t-, and Ma1m-Whitney tests, 
depending upon the number o f comparisom. p < 0.05 was considered 
statistically significant. 
RESULTS 
Transfer of Autologous Peripheral Blood Lymphocytes to 
Human Skin Explants Does Not Maintain the Psoriatic 
Phenotype Lesional skin from six p soriatic patients w as grafted 
onto SCID mice, and the mice were subseque ntly injected with 
auto logous PBMC that had b een cultured i11. 1itro as d escribe d . The 
PBMC were injected either ID (2. 7 X 106 cells /graft) or IV (2 .6 X 
106 cells/graft). Control grafts on SCID mice w e re not injected. 
After 6 wk, the control grafts showed a decrease in both epidermal 
thickness (p < 0 .05 , t test on means) (Table I) and labeling index 
(Table I) re lative to the va lues o f the initial psoriatic skin. Injection 
of autologou s cultured PBMC into p soriatic skin explants did not 
prevent this decrease in e pide m1al thickness and labeling index. 
Injection of Autologous Skin Infiltrating T Cells Can Main-
tain Psoriatic Features, Including Epidermal Thickness, 
and Labeling Index Skin infiltrating lymphocytes were isolated 
from both p soriatic and normal skin and inj ected into SCID mice 
transplante d with autologous lesional p soriatic or n ormal skin as 
appropriate . Lymphocytes were injected IV or ID as indi ca ted . 
Control SCID mice transplante d with sk.in explants were not 
injected with T cell s. Ten weeks following the injections, the 
psoriatic grafts were removed and evalu ated. Only those psoriatic 
grafts that had been injected with autologous skin-inft.ltrating T 
cells expressed the full histologic features of psoriasis. Prior to 
engraftment to SCID mice, the epidermis of the p smiatic grafts was 
significantly thicker than that of the normal grafts (Fig 1). Injection 
of autologous skin-infiltrating cells either IV or ID was ab le to 
maintain the sk.in thickness of the psoriatic grafts (Fig 1). Epidermal 
thickness was found to regress in psoria tic sk.in explants on 
noninjecte d mice. Injec te d psoriatic explants retained features of 
psoriasis including capillary dilatation, e longation of rete ridges, 
dermal mononuclear cell infiltration, parakeratosis, and loss of the 
grannlar layer (Fig 2). In contrast, these features were absent in 
normal skin explants. 
Comparison oflabeling indices for psmiatic and nonnal skin (Fig 
3) revealed a significant diB:erence both before and following 
engraftment (ANOVA: p < 0 .05). No difference was found b e tween 
p soriatic skin prior to grafting vers11s ID injected explants. Labeling 
indices of the 10 injected psoriatic grafts w ere significantly higher than 
tl10se of the non.injected grafts (ANOVA: p < 0 .05) . In contrast, 
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Figure 1. Injection of lesional T cells maintains the epidermal 
thickness of psoriatic skin grafts. Epidermal thi ckness (microns ::':: SEM) 
of normal and psoriatic lesional skin explants on SCID mice. T cells were 
injected into the SCID mice either IV , or lD into the gra fts. T he thickness 
of noninjected psoriatic skin was significantly different from the initial va lue, 
as well as that of the injected grafts (p < 0.05 by ANOVA). 
injection of skin-inftltrating T cells from normal skin into autologous 
normal skin explams had no effect on labeling index (Fig 3). 
The number ofT cells in noninjected grafts of normal or psoriatic 
skin decreased in both the epidermis and dermis 10 wk following 
engraftment (Table II) (p < 0.0001, ANOVA). T he numbe.r ofT 
cells in psoriatic grafts from ID and IV injected mice was statistically 
equiva lent to that fo und in the skin explants prior to engraftment. 
CDS+ cells m ade up a significant proportion of the epidermal T 
cells in both pre-injected and inj ected psoriatic skin (Table II and 
Fig 4) . The decrease observed in the non-injected grafts was 
statistica lly signiftcant (p < 0.0001, AN OVA) for all cells except for 
CDS+ cells in the norm al epidermis. In all cases, there were more 
T -cel.ls in psoriatic skin group than in the normal skin treatment 
group (p < 0.0001, ANOVA). Infiltrates of human T cells w ere 
observed only in the human skin grafts and not within the murine 
skin . The numbers ofT cells in normal skin grafts, both with and 
without inj ection, were much lower than in psoriatic skin grafts. 
Lymphocytes within the human skin grafts were negative for 
murine CD3 or natural killer cellular markers. 
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A 
PRIOR TO GRAFTING 
NON·INJECTED 
INTRADERMAL T-CELLS 
INTRA VENOUS T-CELLS 
0 4 8 12 16 
LABELING INDEX OF PSORIATIC GRAFTS 
B 
PRIOR TO GRAFTING 
NON-INJECTED 
INTRADERMAL T·CELLS 
INTRAVENOUS T-CELLS 
0 2 4 6 8 
LABELING INDEX OF NORMAL GRAFTS 
Figure 3. Injection of skin-infiltrating cells from psoriasis lesions, 
but not normal skin, maintains the elevated labeling index of skin 
grafts. Labeling i.ndex ( ::':: SEM) of grafts on SCID mice: (A) Psoriatic 
grafts, LD inj ected grafts ''erSIIs noninjected grafts (p < 0.05). (B) Nonnal 
grafts. 
HLA-DR and ICAM-1 Expression by Psoriatic Keratino-
cytes Was Dependent upon IV Injection of Lymphocytes 
HLA-DR expression was observed prior to engraftment i1~ ten of14 
grafts . After transplantation, expression of HLA-DR was lost in 
noninjected grafts but was retained in the ID T cell-injected grafts 
(Figs 4,5) . Prior to engraftment, ICAM-1 was observed in eight of 
14 grafts (57'%). ICAM-1 expression decreased slightly in tl1e 
noniJ'tiected grafts and was elevated in grafts injected with T cells 
either ID or IV (Figs 4,5). HLA-DR and ICAM-1 expression was 
not observed in the epidermis of normal skin explants, regardless of 
T-cell it'tiections (data not shown). 
Transfer of Autologous T Cells Maintains the Disordered 
Differentiation Characteristic of Psoriasis Involucrin ex-
pression throughout the epidermis is a characteristic feature of 
Figure 2. Injection of lesional T cells maintains the pathology of psoriatic skin grafts. (A) Psoriati c lesional skin explants following 10 wk. of 
engraftment onto SCID mice and IV injection of autologous cul tured s.kin-infll trating T cell s. (B) Psoriatic lesion a! skin not injected with lymphocytes. Mouse 
skin containing hai r follicles is present on the right side of figure. 
Table II. Injection ofT Cells Reconstitutes Cutaneous T Cell Numbers in Psoriasis Grafts" 
Treatn1 ent 
Normal skin grafts (n 
Pre g rafting 
Not injected 
ID inj ection 
IV iqjection 
Psoriatic skin grafts (n 
Pregrafting 
Not injected 
ID injection 
IV i11iection 
9) 
14) 
n V;1lues are expressed as the mean ± SD . 
CD3 + Cells 
Epidermis Dennis 
8 :t 1 33 :t 13 
3 :t 2 13 :t 9 
9 ± 4 18 :t 8 
13 ± 5 22 ± 10 
55 ± 24 163 :t 65 
24 :t 8 30 :t 14 
53 :t 21 110 :t 61 
52 :t 22 144 :t 55 
CD4 + Cells CDS + Cel.l s 
Epidermis Dermis Epidermis 
7 :t 5 41 :t 23 0.3 :t 0.1 
2 :t 1 18 ± 10 0 .9 ± 0.2 
5 :t 2 18 :t 9 0.8 ± 0.3 
8 :t 6 23 :t n 5.0 ± 2.0 
34 :t 15 129 :t 56 42 ± 16 
19 ± 5 34 :t 20 11 ± 6 
30 :t 12 58 ± 31 40 ± 28 
33 :t 13 62 :t 31 31 ± 18 
Dennis 
18 :t 6 
8 ± 2 
9 :t 3 
8 :t 4 
76 :t 21 
17 ± 9 
43 ± 26 
37 :t 18 
Figure 4. Injection of lesional T cells into psoriasis grafts results in infiltration of CDS + cells in the epidermis, abnormal epidermal 
differentiation, and ICAM-1 expression. (A) Immunohistochemica l staining of psoriatic skin grafted and injected LV with autologous lymphocytes. 
Human CDS + lymphocytes are scattered throu ghout the epidermis. (B) Normal skin injected TV wi th autologous lymphocytes. N ote the paucity of 
infil trating CDS + cells. (C) lnvo lucrin expression along the epidermis, i11 psoriatic grafts i11j ected IV with auto logous T cell s. (D) lnvolucrin expression in 
skin graft fro m normal subject i11i ected with autologous T cells (epidermis is down). (E) IC AM-1 express ion by kcratin ocytes in psoria tic lesional skin grafts 
injected IV with autologous T cell s. 
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Figure 5 . Percentage of psoriatic lesional skin grafts (n = 14) 
expressing HLA-DR and ICAM-1 prior to grafting and after injec-
tion of skin infiltrating T cells. 
psonas1s (S chroeder et a!, 1992) . In normal skin, by contrast, 
involucrin staining is mostly confined to the granular cell layer. 
Following engraftment of ps01iatic explants, expression of involu-
crin from the midepidermis to the stratun.1 corneum was reduced 
compared to initial levels. lnvolucrin expression, however, was at 
initial levels in psoriatic explants from mice injected with autolo-
gous skin infiltrating T cells (Figs 4,6). In normal skin grafts, 
involucrin staining was observed only in the stratum granulosum 
(data not shown) . 
Filaggrin is a granular layer-associated protein that is deficient in 
psoriatic skin (Bernard et a/, 19SS). Prior to grafting, filaggrin was 
present in the normal skin (9 /9) but absent in all (14/14) of the 
psoriatic explants. Following 10 wk of engraftment, fi laggrin was 
still expressed in the normal skin (9/9). Fi laggrin was then , 
however, expressed in the majority of the noninjected psoriatic 
grafts (S/12) . Lack of ftlaggrin expression was maintain ed by the 
injection ofT cells either IV or lD (Fig 6). 
Cytokeratin- 16 (K-16) expression is a marker of hyper-prolifer-
ation (Thewes ef a/, 1991) and was noted throughout the epidermis 
of psoriatic grafts both before (1 0/12) and after engraftment, both 
in injected (11/14) and non-injected (9/12) grafts. Nom1al skin 
grafts did not express K-16 . 
Human T Cells in the Spleens of Injected SCID Mice 
Spleens of grafted mice were analyzed for human T lymphocytes 6 
wk following lymphocyte administration. Spleens from IV injected 
mice contained a mean of 27% :±: 16% human T cells (range 
52%- 9.4%), compared to 10 .S% :±: 3 .5'Yo (range 16.5°;(1-5.2%) for 
mice injected ID (post hoc N eu.mann-Keuls test, p < 0.05 for IV 
versus ID comparison) . Cytospin analysis using anti-human CD3 
PRIOR TO GRAFTING 
NON-INJECTED 
INTRADERMAL T-CELLS 
INTRAVENOUS T-CELLS 
0 20 40 60 80 100 
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B! INVOLUCRIN 
• LACKING FILAGGRIN 
Figure 6. Percentage of psoriatic lesional skin grafts (n = 14) 
expressing involucrin below the granular layer and lacking filag-
grin expression. 
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antibodies confirmed these findings as well as an absence of murine 
CD3-posi tive T cells in the spleens of the SCID mice . 
DlSC USSION 
When human psoriatic skin was grafted onto SCID mice, the skin 
gradually lost many of its psoriatic fea tures . Transfer ofT cells from 
psoriasis lesions was able to m aintain the psoriatic phenotype. 
Features of psoriasis that were maintained included epidermal 
acanthosis, elevated labeling index, keratinocyte expression of 
ICAM-1 and HLA-DR, involucrin staining below the stratum 
granulosum, and an absence of filaggrin. T cells injected by either 
the ID or IV route were distributed in both the epidermis and 
dermis u1 numbers sunilar to initial levels. T hese data indicate tl1at 
T cells have a direct role in the maintenan ce of tl1e psoriatic 
pathology. 
Injection of autologous skin- infiltrating T cells into normal skin 
from nonpsoriatic donors had no effect on either epidermal thick-
ness or labeling index. Furthermore, PBMC from psoriatic patients 
were not able to maintau1 psoriasis , as this effect was specific for 
lesiona l T cells. T cells frorn all sources were similarly activated and 
cultured with IL-2. Thus, the maintenance of psoriasis by lesional T 
cells was not a nonspecific effect of activated T -cells. The relative 
lack ofT cells withi n the human dermis of nonual skin grafts after 
ID injection, as compared to the psoriatic grafts, may reflect the 
elrpression of addressins by lesional psoriati c skin . 
Engraftment of psoriatic skin onto nude mice leads to regression 
of the histologic and immunologic features of psoriasis (Krueger et 
al, 19S1 ; Fraki eta/, 19S2; Gilhar et a/, 1996a,b) . T his regression 
correlates with the elimination of infiltrating human T cells within 
the psoriatic skin (Gilhar el al, 1996a). SCID mice d iffer from nude 
mice u1 that infiltrating lymphocytes are less readily eJjminated from 
human gra fts, which may e).."jJ lain the partial mau1tenance of 
psoriatic features in noni.nj ected grafts. 
There is considerable u"tdi.rect evidence for a role ofT cells in the 
pathogenesis of psoriasis. T cells within ps01i asis lesions are acti-
vated and express HLA-DR and IL-2 receptors and secrete the 
cytokines IL-2 and interferon- -y (Valdimarsson eta/, 19S6; Gottlieb, 
19SS; Nicoloff, 1991; Bata- Csorgo eta /, 1995). [nterferon- -y inter-
acts with epidem1al keratinocytes to induce the expression of 
ICAM-1 and HLA-DR by keratinocytes. 
R ecently, both Boehncke et al (1996) and Wrone-Smith and 
Nickoloff (1996) demonstrated that psoriasis can be induced u1 
human skin grafts on SCID mice by the iruection of superantigen-
activated leukocytes. These two studies, along with ours, support a 
direct role for activated T cells in the pathogenesis of ps01iasis. 
T hese studies differ from ours in that psoriatic changes were 
u1duced in nonlesional skin, whereas in our study, the psoriatic 
phenotype was maintained in lesional skin . In addition , both of tl1e 
above studies used superantigen- stimu lated PBMC. Superantigens 
bu1d to HLA-DR to stimulate T cells and thus should interact 
differently with CD4 + cells (Leung et al, 1995). Nickoloff et a/ have 
recently demonstrated that in their model, ps01;asis is mediated by 
CD4 + cells. 2 T lus runs counter to evidence suggesting that psori-
asis is mediated in part by epidermal CDS+ cell s (GottJjeb cf a/, 
1995) . Our immunohistochemistry analysis also detected CDS+ 
cells in the epidermis of psoriatic plaque, both initially and after 
injection of lesional T cells. Although the superantigen model is 
extremely usefu1, it m ay not identify the autoreactive T cell that 
itutiates psoriasis. 
Injection of PBMC cultured with IL-2 did not maintain the 
psmiatic phenotype, whereas lesional psmiatic T cells did have this 
ability. It is proposed that the frequency of pathogenic autorea.ctive 
T cells is higher in skin lesions than u1 th e peripheral blood . This 
would be analogous to the enrichment of urushiol-specific T cells 
found in allergic contact dermatitis lesions induced by urushiol 
2 N ickoloff BJ , Gutierrez-Steil G, Wronc-Smith T: Dcnnal injection of 
CD4 + T cell s into symptomless (PN) skin engrafted onto SCID mice 
induces phenotypic conversion to a psoriatic plaque (PP). J h 111cst D ermntol 
108:539, 1997 (abm). 
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(Kalish and Johnson, 1990). T he T cells were ac tivated i11 11itro by a 
combination of lL-2 and epithelial antigen rather than by superan-
tigen. An alternate explanation is th at th e lesional skin T cells may 
preferentia lly express the cutaneous lymp hocyte antigen homin g 
receptor. lt is possible that this model of psoriasis may be useful for 
identifying the autoreactive T ce iJ that indu ces psoriasis. 
Grafting of human psoriatic lesionaJ or nonlesional skin onto 
SCID mice is a powerful tool that has already been used to 
investigate pharmacologic manipul ation of psoriasis. 3 T he con trast 
of our res ults to those obtain ed with the inj ection of superantigen-
activated PBMC raises the question of wh at is unjque about lesional 
psoriatic T cell s and supcrantigen-activated PBMC that favors the 
development of psm;atic changes. ln summary, our results are 
direct evidence that psor.iasis is mediated by and dependent on T 
ceiJs. 
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